OLR1 and respiratory tract infectious disorder: Here we demonstrate substantial accumulation of LOX-1 and its ligands in the airspaces of both mice and humans with pneumonia, supporting a potentially novel precedent for LOX-1–mediated activity in response to respiratory infections.